Agonist, antagonist, and inverse agonist properties of antipsychotics at human recombinant 5-HT1A receptors expressed in HeLa cells

European Journal of Pharmacology

Volumn 433, Issue 1, 2001, Pages 55-62

  Cosi, Cristina ^a   Koek, Wouter ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

5 HT1A receptor; 35S GTP S binding; Antipsychotic; HA7 cell; Inverse agonism

Indexed keywords

2,3,3A,12B TETRAHYDRO 3 METHYL 1H DIBENZO[B,F]OXEPINO[10,11 C]PYRROLE; CHLORPROMAZINE; CLOZAPINE; EMONAPRIDE; HALOPERIDOL; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; NEUROLEPTIC AGENT; OCAPERIDONE; OLANZAPINE; PIMOZIDE; RACLOPRIDE; RISPERIDONE; SEROTONIN 1A RECEPTOR; SERTINDOLE; THIORIDAZINE; TIOSPIRONE; ZIPRASIDONE;

ARTICLE; DRUG ACTIVITY; DRUG EFFICACY; DRUG PROTEIN BINDING; HELA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION;

ANTIPSYCHOTIC AGENTS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HELA CELLS; HUMANS; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; RECOMBINANT PROTEINS; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SODIUM;

EID: 0035861850     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01493-5     Document Type: Article

References (25)

1. Prevention by (±)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol
2. 1A receptor agonist properties of the antipsychotic, nemonapride: Comparison with bromerguride and clozapine
3. 1A receptor in schizophrenia: A promising target for novel atypical neuroleptics?
4. 1A receptors
5. Inverse agonism at G protein-coupled receptors: (Patho)physiological relevance and implication for drug discovery
6. 1A receptor signaling by point-mutation of cyteine351 in the rat Gαo protein
7. 1A receptor
8. Evidence that antipsychotic drugs are inverse agonist at D2 dopamine receptors
9. A controlled clinical trial of tiospirone in schizophrenia
10. 1A receptors
11. Reversal of neuroleptic-induced catalepsy by novel aryl-piperazine anxiolytic drugs
12. Tiospirone in schizophrenia
13. 1A receptors
14. 1A receptors by the inverse agonist, spiperone but not the neutral antagonist, WAY 100635
15. 35S] GTPγS binding study
16. 1A receptor agonists in recombinant cell lines: Modulation of apparent efficacy by G-protein activation state
17. Effects of dopamine antagonists in a two-way active avoidance procedure in rats: Interactions with 8-OH-DPAT, ritanserin, and prazosin
18. sα
19. 1A receptor: G protein and signaling pathways
20. 1A receptor activation
21. Ziprasidone (CP-88,059): A new antipsychotic with combined dopamine and serotonin receptor antagonist activity
22. 1A receptor system: Possible implications for schizophrenic negative symptomatology
23. 35S] GTPγS binding
24. Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: Enhancement of antipsychotic-like effects without catalepsy
25. Pharmacological and neurochemical studies with the new antipsychotic ziprasidone